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Abstract
This study aimed at developing an alternative host for the production of penicillin (PEN). As yet, the industrial production of
this b-lactam antibiotic is confined to the filamentous fungus Penicillium chrysogenum. As such, the yeast Hansenula
polymorpha, a recognized producer of pharmaceuticals, represents an attractive alternative. Introduction of the P.
chrysogenum gene encoding the non-ribosomal peptide synthetase (NRPS) d-(L-a-aminoadipyl)-L-cysteinyl-D-valine
synthetase (ACVS) in H. polymorpha, resulted in the production of active ACVS enzyme, when co-expressed with the
Bacillus subtilis sfp gene encoding a phosphopantetheinyl transferase that activated ACVS. This represents the first example
of the functional expression of a non-ribosomal peptide synthetase in yeast. Co-expression with the P. chrysogenum genes
encoding the cytosolic enzyme isopenicillin N synthase as well as the two peroxisomal enzymes isopenicillin N acyl
transferase (IAT) and phenylacetyl CoA ligase (PCL) resulted in production of biologically active PEN, which was efficiently
secreted. The amount of secreted PEN was similar to that produced by the original P. chrysogenum NRRL1951 strain (approx.
1 mg/L). PEN production was decreased over two-fold in a yeast strain lacking peroxisomes, indicating that the peroxisomal
localization of IAT and PCL is important for efficient PEN production. The breakthroughs of this work enable exploration of
new yeast-based cell factories for the production of (novel) b-lactam antibiotics as well as other natural and semi-synthetic
peptides (e.g. immunosuppressive and cytostatic agents), whose production involves NRPS’s.
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Introduction
b-Lactam antibiotics (penicillins and cephalosporins) represent a
class of important drugs of major clinical value. Their significant
economical value is evident from the fact that b-lactam antibiotics
contribute to over 40% of the total antibiotic market [1]. The industrial
production of penicillin (PEN) occurs via fermentation using the
filamentous fungus Penicillium chrysogenum. There is considerable interest
in developing novel cell factories for the production of (new) b-lactam
antibiotics, because of the intrinsic drawbacks of filamentous fungi for
large scale industrial fermentations. Unicellular yeast species are very
attractive alternatives as they have superior fermentation characteristics
over filamentous fungi. Production of PEN and other b-lactam
antibiotics in yeast will also provide new opportunities for highly
sustainable production processes and the development of generic
strategies to produce modified b-lactams and eventually other peptide
antibiotics using the power of yeast genetics.
The yeast Hansenula polymorpha, a recognized producer of
pharmaceuticals [2], represents an attractive alternative for PEN
production. Advantages of this organism include the availability of
very strong and regulatable promoters and excellent fermentation
properties. An example includes the large scale industrial
production of hepatitis B antigen [2]. Also, in this yeast peroxisomes
can be massively induced. This is a favorable property to facilitate
PEN production, which is known to involve peroxisomal enzymes.
Adapting yeast to produce PEN requires the introduction of the
complete PEN biosynthetic pathway in the organism. This involves
the non-ribosomal peptide synthetase (NRPS) d-(L-a-aminoadipyl)-
L-cysteinyl-D-valine synthetase (ACVS), isopenicillin N synthase
(IPNS), isopenicillin N acyl transferase (IAT) and phenylacetyl CoA
ligase (PCL). Of these, ACVS and IPNS are cytosolic, whereas IAT
and PCL are localized to peroxisomes (Fig. 1) [3]. Notably, ACVS
belongs to a class of enzymes (NRPS’s) that exclusively occurs in
certain filamentous fungi and bacteria (Actinomycetes, Bacilli).
Here we show that we successfully engineered H. polymorpha to
produce biologically active PEN. Our work involves major
breakthroughs by showing:
1. the functional expression of an NRPS in yeast,
2. the successful reconstitution of the complete, compartmental-
ized PEN biosynthetic pathway in H. polymorpha
3. that PEN is highly efficiently secreted by H. polymorpha.
4. that the peroxisomal localization of the last two enzymes of the
PEN biosynthesis pathway is important for efficient PEN
production.
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8317These achievements are of major significance for the develop-
ment of novel yeast-based production platforms for the production
of novel b-lactams and other important peptide-based pharma-
ceuticals.
Results
Functional Production of ACVS in H. polymorpha
In our approach to reprogram H. polymorpha to produce PEN, we
first set out to generate a strain synthesizing enzymatically active
A C V S ,a4 5 0k DN R P S .U p o ni n t r o d u c t i o no ft h eP. chrysogenum pcbAB
gene encoding ACVS in H. polymorpha (strain HpPen1), the protein was
properly produced and localized to the cytosol (Fig. 2 and 3). However,
when these cells were grown in the presence of the ACVS substrate a-
aminoadipic acid (AAA), ACV production could not be demonstrated
(Fig. 4). This was most likely related to the fact that activation of NRPS
enzymes requires covalent attachment of a phosphopantetheinyl
moiety to the peptidyl carrier protein domain of the enzyme [4], a
reaction that is catalyzed by phosphopantetheinyl transferases
(PPTases). Apparently, H. polymorpha does not contain a PPTase that
is able to activate ACVS in vivo. Therefore, we introduced the Bacillus
subtilis PPTase Sfp, which exhibits a broad substrate specificity [5], in
HpPen1, thus generating strain HpPen2 (Fig. 3).
When HpPen2 was grown in the presence of AAA, ACV was
indeed produced (Fig. 4), demonstrating that B. subtilis Sfp had
activated ACVS. ACV was not observed when HpPen2 cells were
grown in the absence of AAA (Fig. 4), which indicates that AAA is
a limiting substrate in H. polymorpha, but can be taken up by the
yeast cells from the cultivation medium.
Secretion of a Bioactive b-Lactam by H. polymorpha
Subsequently, we introduced P. chrysogenum IPNS in HpPen2 to
produce IPN, the next intermediate of the PEN biosynthesis
pathway [6] (Fig. 1). In the resulting strain (HpPen3), ACVS, Sfp
and IPNS were properly produced (Fig. 3). Upon growth of these
cells in medium containing AAA, intracellular accumulation of a
b-lactam antibiotic (presumably IPN) could be demonstrated in a
Figure 1. Schematic representation of the penicillin G (PenG) biosynthetic pathway in P. chrysogenum. In the cytosol, the enzyme ACVS
(ACVS-OH) is activated by a PPTase into ACVS-SH. The active enzyme produces ACV from the three precursor molecules AAA, L-cysteine and L-valine.
IPNS subsequently converts ACV into the b-lactam IPN, which is transported into peroxisomes. In this organelle PAA is activated by PCL into
phenylacetyl CoA (PA-CoA), which is used by IAT to synthesize PenG from IPN. PenG is exported from the organelle and ultimately secreted into the
medium. The precursors and intermediates of PenG biosynthesis pathway are boxed.
doi:10.1371/journal.pone.0008317.g001
Figure 2. Subcellular localization of ACVS in H. polymorpha.
Immunocytochemistry using anti-ACVS antibodies showing the pres-
ence of ACVS protein in the cytosol of strain HpPen4. Cells were fixed in
3% glutaraldehyde for 1 h on ice, dehydrated in an ethanol series and
embedded in Lowicryl, polymerized by UV light. Post-staining was with
0.5% uranylacetate. M – mitochondrion; P – peroxisome; V – vacuole.
The bar represents 0.5 mm.
doi:10.1371/journal.pone.0008317.g002
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luteus [7] (Fig. 5A). Growth of this indicator strain was not inhibited
when an extract was used of similarly grown HpPen2 control cells
(Fig. 5A). The presence of enzymatically active ACVS and IPNS
in cells of strain HpPen3 to form IPN was confirmed using an in
vitro assay (Fig. 5B).
PEN Production in Yeast
As a final step to produce PEN in H. polymorpha, we introduced
the genes that encode the P. chrysogenum peroxisomal enzymes IAT
and PCL in HpPen3, resulting in strain HpPen4 (Fig. 3). We
previously showed that both heterologous proteins are properly
synthesized and sorted in H. polymorpha [8,9]. To test whether
HpPen4 cells produced and secreted the b-lactam antibiotic
penicillin G (PenG), cells were grown in media supplemented with
AAA and phenylacetic acid (PAA), the PenG side chain precursor.
As shown in Fig. 5C (extracellular), a clear zone of growth
inhibition of M. luteus was observed in the bioassay using spent
medium of the HpPen4 culture. Growth inhibition was not
observed when medium of a control HpPen3 culture was used.
This data suggests that PenG is produced and secreted by HpPen4
cells.
LC-MS/MS analyses of spent medium of the HpPen4 culture
confirmed the presence of compounds that have the same accurate
masses as PenG and IPN (Fig. 6). Furthermore, MS/MS
fragmentation patterns of these substances were identical to those
obtained using pure IPN or PenG (Fig. 6).
Interestingly, using the same volume of spent media of cultures
of P. chrysogenum NRRL1951 and HpPen4 halo’s of similar size
were obtained in the bioassay (Fig. 5C). P. chrysogenum NRRL1951
is the strain from which all subsequent high producing strains are
derived.
Halo’s were also observed when crude extracts were used of
HpPen3 or HpPen4 cells, which had been grown in the presence
of AAA and PAA (Fig. 5C intracellular). However, extracts
corresponding to large culture volumes (100 times more than of
the spent medium) had to be used to obtain these halo’s (Fig. 5C).
In HpPen3 cell extracts the halo is most likely due to the
accumulation of IPN, whereas for HpPen4 cells residual amounts
of PenG and IPN may remain inside the cells.
PEN Is Efficiently Secreted by HpPen4 Cells
Subsequent detailed quantitative analysis of IPN and PenG
using ion-pair reversed-phase liquid chromatography–electrospray
ionization isotope dilution tandem mass spectrometry (IP-LC–
ESI-ID-MS/MS) confirmed that IPN indeed accumulates inside
HpPen3 cells (Fig. 7). In identically grown HpPen4 cultures the
level of intracellular IPN was reduced relative to those in HpPen3
cells. However, these cells produced PenG, which was predom-
inantly present extracellularly, confirming that PenG is secreted by
HpPen4 cells. Calculation of the intracellular metabolite concen-
trations revealed that PenG is efficiently secreted by HpPen4 cells
(the ratio of the extracellular/intracellular concentration of PenG
is 24). However, how PenG and its intermediates are transported
over the peroxisome and plasma membrane is still largely
speculative. Recently, the presence of a regulatable porin in the
peroxisomal membrane has been described [10] that could be
involved in this process. The HpPen4 cells also produced low
concentrations of 6-amino penicillinic acid (6-APA), which was
barely detectable in HpPen3. In HpPen4 cells 6-APA is most likely
formed by hydrolysis of IPN [11]. In line with the analyses shown
in Fig. 6, IPN was also detectable in the medium of HpPen4
cultures. The amount however was too low to allow accurate
quantification using the IP-LC–ESI-ID-MS/MS method used.
Peroxisomes Are Important for Efficient PEN Production
To analyse the importance of the peroxisome compartment in
PEN-producing H. polymorpha cells, we analyzed PenG production
in HpPen4 cells in which the PEX3 gene was deleted (Dpex3
HpPen4).
Figure 3. Expression of genes involved in penicillin G
production in H. polymorpha. Western blot analysis demonstrating
the presence of ACVS, Sfp, IPNS, IAT and PCL in cells of the various
indicated H. polymorpha strains grown in batch cultures on methanol.
The blots were decorated with the indicated antibodies except for Sfp,
which was produced as a His6 tagged protein and detected by anti-His6
antibodies. Per lane 20 mg of protein was loaded, except for IPNS for
which 2 mg of protein was used.
doi:10.1371/journal.pone.0008317.g003
Figure 4. ACV production in HpPen2. Multiple reaction monitoring
(MRM) chromatograms from ACV in extracts of strains HpPen1 and
HpPen2 cells grown in batch cultures on methanol in the presence
(+AAA) or absence (-AAA) of 8 mM AAA. The data show that ACV is only
present in HpPen2 cells grown in the presence of AAA (lowest panel).
An MRM chromatogram from the co-eluting
13C labeled ACV internal
standard is included as control (upper panel).
doi:10.1371/journal.pone.0008317.g004
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as Dpex3 HpPen4 cells can not grow on methanol. Deletion of
PEX3 in H. polymorpha results in the complete absence of
recognizable peroxisomal structures and the mislocalization of all
peroxisomal enzymes to the cytosol [12]. Bioassays revealed that a
significantly smaller halo was formed using medium of the Dpex3
HpPen4 culture relative to HpPen4 medium (Fig. 8). This was
confirmed by MS/MS data, which indicated that in glucose/
choline grown cells the PenG production had decreased over 50%
(1.1 mg/ml in HpPen4 vs 0.4 mg/ml in Dpex3 HpPen4). Hence,
compartmentalization of IAT and PCL in peroxisomes is
important for efficient PenG production in H. polymorpha.
Discussion
Here we present a proof of principle that cells of the yeast H.
polymorpha can be engineered to produce the important b-lactam
antibiotic PEN by introduction of four P. chrysogenum genes and one
B. subtilis gene. This achievement includes several major
breakthroughs. First, we show the functional expression of an
Figure 5. Production of b-lactam antibiotics in H. polymorpha. (A) In vivo production of IPN by HpPen3 cells. HpPen3 cells were grown in a
methanol-limited chemostat in the presence of 8 mM AAA. Cell extracts (corresponding to 1250 ml culture) were loaded in a well of a bioassay plate,
which had been overlayed with the indicator strain M. luteus. After incubation of the plate, a halo, representing a zone of growth inhibition, was
observed indicating that an antibiotic compound was produced. A halo was not observed when an extract of identically grown cells of the HpPen2
control strain were used. (B) In vitro production of IPN using HpPen3 cell extracts. Cell extracts were prepared from methanol grown HpPen3 cells and
a volume corresponding to 500 microgram of protein was used for in vitro IPN synthesis. As a control, a desalted cell extract of P. chrysogenum
DS17690 cells (250 mg protein) was used. Extracts were incubated in the presence of ATP and the amino acids AAA, L-cysteine, L-valine and
subsequently loaded in a well of a bioassay plate, which had been overlayed with the indicator strain M. luteus. After incubation of the plate, a halo
was observed indicating that an antibiotic compound was produced. This halo was absent in the control experiments performed without ATP or
when b-lactamase was added to the reaction mixture. (C) Secretion of antibiotic compounds by HpPen4 cells. HpPen3 and HpPen4 cells were grown
in continuous cultures on a mixture of glucose and methanol in the presence of 1 mM AAA and 1 mM PAA. A small aliquot (12.5 ml) of the spent
medium of HpPen4, but not HpPen3 cultures, resulted in growth inhibition of the indicator strain (panels marked extracellular) on bioassay plates.
Using crude cell extracts (panels marked intracellular) of HpPen3 and HpPen4 cells antibiotic compounds were detected as well. The amount of crude
extracts used for the bioassay corresponded to 1250 ml of the culture volume. (D) HpPen4 cells secrete comparable amounts of antibiotics relative to
P. chrysogenum NRRL1951. HpPen4 cells were grown in batch cultures on methanol in the presence of 1 mM PAA and 1 mM AAA. P. chrysogenum
NRRL1951 cells were grown in batch cultures on production medium in the presence of 3 mM PAA. The figure shows that similar amounts of
antibiotics are secreted by both organisms. 25 ml spent medium of both cultures was used.
doi:10.1371/journal.pone.0008317.g005
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compartmentalized biosynthetic pathway in yeast that is catalyzed
by cytosolic and peroxisomal enzymes and requires transport of
precursors, intermediates and end products across the peroxisomal
and plasma membrane (Fig. 1). Finally, we demonstrate that intact
peroxisomes are required for efficient product formation.
Functional expression of the NRPS ACVS in H. polymorpha was
dependent on the function of a heterologous PPTase, to modify
the protein by covalent binding of phosphopantetheinyl moieties.
Apparently, the endogenous H. polymorpha PPTase (Lys5) is unable
to activate ACVS, whereas the broad specificity bacterial enzyme
is suitable for this modification and functional in vivo in H.
polymorpha. While this paper was under review [13] published a
similar result, expressing functional ACVS in baker’s yeast.
Functionally expression of an NRPS in yeast opens the way to
explore novel and improved processes to produce other NRPS-
based natural peptides in this cell factory. NRPS’s allow synthesis
of a broad range of valuable compounds, including almost all
peptide-based antibiotics as well as other clinically important
compounds such as immunosuppressors and anti-tumor
compounds [14].
Our data open the way to use yeast as a host organism for
NRPS engineering. NRPS engineering is a strongly emerging field
[15,16] with ample opportunities to develop novel products and
processes. These developments rely on efficient NRPS production
systems that have now become available in yeast. A single NRPS
consist of an arrangement of modules, in which each module is
responsible for the incorporation and modification of one amino
acid building blocks in the growing polypeptide chain. This
modular structure of NRPS’s renders them highly attractive
targets for protein engineering by domain swapping or active-site
modifications. Taking advantage of the power of yeast genetics
and handling, our finding offers important novel options that
highly facilitate NRPS engineering.
In P. chrysogenum, PEN production is compartmentalized in
peroxisomes and the cytosol. The efficient secretion of PEN
produced in H. polymorpha indicates that highly dedicated P.
chrysogenum transporter proteins apparently are not required for the
intracellular transport processes, for uptake of PAA and AAA, nor
for the efficient secretion of the end product. Also, compartmen-
talization is important for efficient PEN production, as the PEN
production levels were reduced in a peroxisome deficient (Dpex3)
background. In Aspergillus nidulans a relation between peroxisome
function and PEN production was observed as well [17]. Why the
peroxisomal localization of IAT and PCL is important, remains
however obscure.
The current non-optimized H. polymorpha strain produces similar
amounts of PEN as the original P. chrysogenum strain (NRRL1951).
Future up-scaling programs will strongly benefit from the
advanced molecular toolbox available for H. polymorpha [2,18,19]
Figure 6. H. polymorpha cells produce and secrete PenG: LC MS/MS demonstration of PEN production. Strain HpPen4 was grown in a
glucose/methanol-limited continuous culture in the presence of 1 mM AAA and 1 mM PAA. Spent medium was analyzed by LC-MS/MS. The LC
chromatograms show the presence of IPN (3.45 min; Fig. 6A) and PenG (11.76 min) and a PenG-related product (7.83 min) (Fig. 6C). Fig. 6B and D
show the LC-MS/MS fragmentation patterns corresponding to IPN (Fig. 6B) and PenG (Fig. 6D). The characteristic MS/MS fragmentation pattern of
pure IPN and PenG and their relative abundance are represented in the tables present in Fig 6A and C.
doi:10.1371/journal.pone.0008317.g006
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also be used to rapidly develop novel antibiotics by introducing
additional heterologous genes and high throughput screening
procedures. The development of novel antibiotics is extremely
important because of the continuous combat against antibiotic
resistant bacteria. Because H. polymorpha grows well on various
cheap carbon sources (e.g. methanol), the newly engineered cell
factory also enables producing these components from alternative
and sustainable feedstocks.
Materials and Methods
Microorganisms and Growth
The H. polymorpha strains used are derivatives of NCYC495
ade11.1 leu1.1 [20] and listed in Table 1. All plasmids are indicated
in Table 2.
Yeast cells were grown at 25uC in batch cultures on 0.5%
methanol for 36 hours [6] or in carbon-limited chemostat cultures
[21,22]. Chemostat cultures were grown at a dilution rate of
0.1 h
21, pH 5.0. The feed contained a mixture of glucose (0.25%)
and methanol (0.2%) [22] or glucose (0.25%) and choline (0.2%)
[21].
P. chrysogenum strains DS17690 [23] and NRRL1951 [24] were
grown in batch cultures on a defined PEN production medium
supplemented with 3 mM PAA [25]. Micrococcus luteus ATCC
9341 was used for bioassays and grown on 2 x YT agar plates
containing 2% bacto-tryptone, 1% yeast extract and 1% NaCl at
30uC.
Construction of Plasmids
Plasmid pZ4-pcbAB. To facilitate cloning of the P.
chrysogenum pcbAB gene, a HindIII site was introduced upstream
of the start codon by PCR with the primers ACVS-forward (59
AGAAAGCTTATGACTCAACTGAAGCCAAA-39) and ACVS
reverse (59 CTTATCTAGAAACAATGCGAC 39) using plasmid
pME1213 as template. Subsequently, the resulting 1.1 kb product
was cloned as a HindIII-XbaI fragment into the HindIII+XbaI-
digested vector pHIPZ4. The resulting plasmid was digested with
XbaI+SmaI and an XbaI-SmaI fragment of plasmid pME1213,
containing the remainder of the pcbAB gene, was inserted. The
resulting plasmid, designated pZ4-pcbAB, contains the entire P.
chrysogenum pcbAB gene flanked by the inducible H. polymorpha
alcohol oxidase promoter (PAOX) and the amine oxidase terminator
(TAMO).
Plasmid pG4U-pcbAB. A 13,777 bp NotI-SmaI fragment of
plasmid pZ4-pcbAB, containing the P. chrysogenum pcbAB gene and
the H. polymorpha PAOX region, was inserted into SalI (blunted by
Klenow treatment) + NotI-digested plasmid pHIPG4U. The
resulting plasmid, designated pG4U-pcbAB, contains the entire
P. chrysogenum pcbAB gene flanked by the H. polymorpha PAOX and
TAMO regulatory sequences, a dominant selection marker
Figure 7. Quantification of produced b-lactam compounds in
HpPen3 and HpPen4 cultures. Strains HpPen3 and HpPen4 were
grown in glucose/methanol-limited chemostat cultures in the presence
of 1 mM AAA and 1 mM PAA. b-lactam compounds were quantified by
IP-LC–ESI-ID-MS/MS in spent medium and cell extracts. PenG could not
be detected in HpPen3 cultures, but was clearly detectable in HpPen4
cultures, where it was efficiently excreted into the medium. The PenG
precursor IPN was present in both HpPen3 and HpPen4 cells; however,
the amount was significantly lower in the PenG producing HpPen4 cells.
Concentrations are expressed as mmol/l culture. Samples were taken in
triplicate. The bars represent the standard error (SE).
doi:10.1371/journal.pone.0008317.g007
Figure 8. Deletion of PEX3 results in reduced PEN secretion.
HpPen4 and Dpex3 HpPen4 cells were grown in a glucose-limited
chemostat culture supplemented with choline as nitrogen source in the
presence of 1 mM PAA and 1 mM AAA. Using spent medium of Dpex3
HpPen4 cultures a smaller halo was produced relative to HpPen4. 6 ml
of spent medium of both cultures was used.
doi:10.1371/journal.pone.0008317.g008
Table 1. H. polymorpha strains used in this study.
Strain Description Reference
WT NCYC495 ade11.1 leu1.1 ura3 met6 [8]
HpPen1 WT with integrated PAOX-pcbAB-TAMO cassette This study
HpPen2 HpPen1 with integrated PTEF1-sfp.His6-TAMO
cassette
This study
HpIPNS
#4.2
NCYC495 ade11.1 leu1.1 with integrated
PAOX-pcbC-TAMO cassette
[6]
HpIPNS.
ACVS
HpIPNS #4.2 with integrated PAOX-pcbAB-TAMO
cassette
This study
HpPen3 HpIPNS.ACVS with integrated PTEF1-sfp.His6-TAMO
cassette
This study
HpPen4 HpPen3 with integrated PAOX-penDE-TAMO and
PAOX-pclA
SKL-TAMO cassettes
This study
Dpex3.
HpPen4
HpPen4 with deletion of PEX3 gene This study
doi:10.1371/journal.pone.0008317.t001
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for targeted integration.
Plasmid pA7-Sfp.His6. We first amplified the B. subtilis
sfp.His6 fusion gene with primers Sfp-F (59 GCGGA-
TCCATGAAGATTTACGGAATTTATATGG 39) and Sfp-R
(59 TCGGTC GACTTAGTGATGGTGATGGTGATGAG-
ATC 39) using plasmid pQE60-Sfp.His6 as template. The
resulting PCR product was then inserted as a BamHI-SalI
fragment into BamHI+SalI-digested plasmid pHIPA4, resulting in
plasmid pA4-Sfp.His6. In order to have constitutive expression of
the sfp.His6 gene, the H. polymorpha PAOX region of pA4-Sfp.His6
(flanked by NotI and BamHI sites) was replaced by a NotI-BamHI
fragment containing the H. polymorpha TEF1 promoter of pHIPX7.
The resulting plasmid, pA7-Sfp.His6, contains the B. subtilis
sfp.His6 gene flanked by the H. polymorpha PTEF1 and TAMO
regulatory sequences and the H. polymorpha ADE11 gene as
auxotrophic marker.
Plasmid pBM4-IAT.PCL
SKL. First, we isolated the
blasticidine gene from plasmid pPIC6-A as a 1969 bp BamHI
(blunted by Klenow treatment)-BglII fragment and cloned that
between the SpeI (blunted by Klenow treatment) and BglII sites of
plasmid pHP-penDE resulting in plasmid pB4-IAT. In order to
clone the pclA gene encoding P. chrysogenum phenylacetyl CoA
ligase in plasmid pB4-IAT, plasmid pHIPM4-PCL
SKL was
digested with Spe1 and the resulting 6146 bp fragment was
ligated into XbaI-linearized pB4-IAT, resulting in plasmid pBM4-
IAT.PCL
SKL. In this plasmid the P. chrysogenum penDE and pclA
SKL
genes are both controlled by H. polymorpha PAOX and TAMO
regulatory sequences.
Construction of H. polymorpha Strains
HpPen1 and HpPen2. A H. polymorpha strain producing
ACVS (strain HpPen1) was constructed as follows: Plasmid pG4U-
pcbAB was linearized with Bst1107I in the H. polymorpha URA3
region and transformed into H. polymorpha NCYC495 ade11.1
leu1.1 ura3 met6. Uracil-prototrophic transformants were selected
and also tested for G-418 resistance (50 mg/ml). A strain
producing ACVS was designated HpPen1.
Strain HpPen2 was generated by integration of NdeI-linearized
plasmid pA7-Sfp.His6 in the genome of HpPen1 with selection
on adenine prototrophy and production of both ACVS and
Sfp.His6.
HpPen3 and HpPen4. For the purpose of generating an H.
polymorpha strain expressing all PEN biosynthesis genes, plasmid
pZ4-pcbAB was digested with SspI and used to transform the H.
polymorpha strain HpIPNS #4.2. Transformants were selected on
YPD plates that contained zeocin (300 mg/ml). A strain producing
both ACVS and IPNS was designated HpIPNS.ACVS. For
construction of HpPen3, plasmid pA7-Sfp.His6 was digested with
NotI and KpnI and the resulting 4656 bp DNA fragment was used
to transform strain HpIPNS.ACVS. Adenine prototrophic
transformants were selected. A transformant that produced
ACVS, Sfp.His6 and IPNS was designated HpPen3.
For the purpose of stable integration of the P. chrysogenum pcbDE
and pclA
SKL genes, plasmid pBM4-IAT.PCL
SKL was linerarized
using NdeI in the MET6 locus. The linerarized plasmid was then
transfomed into strain HpPen3. Transformants were selected on
YPD plates with blasticidine (300 mg/ml). A strain producing all
five PEN enzymes was designated HpPen4.
Dpex3.HpPen4. In order to create a peroxisome deficient
derivative of HpPen4, the pex3::nat deletion cassette was PCR
amplified from plasmid pSNA04 with primers pex3-nat-fw ( 59
ACCGCGTGAAACTTTATATCG 39) and pex3-nat-rev (59
CAAGGAACGCGATGTATGTT 39). The resulting 1923 bp
fragment was used to transform HpPen4. Transformants were
selected on YPD plates with nourseothricin (100 mg/ml). Correct
deletion of PEX3 was confirmed using Southern blot analysis. The
resulting strain was designated Dpex3.HpPen4.
Table 2. Plasmids used in this study.
Plasmid Description Source/reference
pHIPG4U Plasmid containing H. polymorpha AOX promoter and AMO terminator regions; H. polymorpha URA3 and G-418
R
markers; Kan
R
Lab collection
pME1213 Plasmid containing P. chrysogenum pcbAB gene; Amp
R Lab collection
pG4U-pcbAB pHIPG4U with P. chrysogenum pcbAB gene under control of H. polymorpha AOX promoter; H. polymorpha URA3 and
G-418
R markers; Kan
R
This study
pHIPZ4 Plasmid containing H. polymorpha AOX promoter and AMO terminator regions; Zeo
R marker; Amp
R [33]
pZ4-pcbAB pHIPZ4 with P. chrysogenum pcbAB gene under control of H. polymorpha AOX promoter; Zeo
R; Amp
R This study
pQE60-Sfp.His6 Escherichia coli plasmid expressing B. subtilis sfp.His6 gene; Amp
R Lab collection
pHIPA4 Plasmid containing H. polymorpha AOX promoter and AMO terminator regions; H. polymorpha ADE11; Amp
R [34]
pHIPX7 Plasmid containing H. polymorpha TEF1 promoter and AMO terminator regions; S. cerevisiae LEU2;K a n
R [35]
pA4-Sfp.His6 pHIPA4 with B. subtilis sfp.His6 gene under control of H. polymorpha AOX promoter; H. polymorpha ADE11; Amp
R This study
pA7-Sfp.His6 pHIPA7 with B. subtilis sfp.His6 gene under control of H. polymorpha TEF1 promoter; H. polymorpha ADE11; Amp
R This study
pPIC6-A Pichia pastoris integration vector; Bla
R, Amp
R Invitrogen
pHP-penDE Plasmid containing P. chrysogenum penDE gene under control of H. polymorpha AOX promoter; S. cerevisiae LEU2; Kan
R [9]
pSNA04 Plasmid containing H. polymorpha pex3::nat deletion cassette; Nat
R; Amp
R [36]
pB4-IAT Plasmid containing P. chrysogenum penDE gene under control of H. polymorpha AOX promoter; Bla
R, Amp
R This study
pHIPM4-PCL
SKL Plasmid containing P. chrysogenum pcl
SKL gene under control of H. polymorpha AOX promoter; H. polymorpha MET6;K a n
R [8]
pBM4-IAT.PCL
SKL pHIPM4-PCL
SKL containing P. chrysogenum penDE gene under control of H. polymorpha AOX promoter; H. polymorpha
MET6;B l a
R,K a n
R
This study
Key: Amp
R, ampicillin resistant; Bla
R, blasticidine resistant; G-418
R, geneticin resistance; Kan
R, kanamycin resistant; Nat
R, nourseothricin resistant; Zeo
R, zeocin resistant.
doi:10.1371/journal.pone.0008317.t002
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Crude extracts of H. polymorpha cells [26] and P. chrysogenum
hyphae [27] were prepared as described previously. Protein
concentrations were determined using the Bio-Rad Protein Assay
system using bovine serum albumin as a standard. Western blots
were prepared using extracts of H. polymorpha and P. chrysogenum
cells, obtained using the TCA method [27], and decorated using
antibodies raised against IPNS, ACVS, IAT, PCL [8,28], or the
His6 tag (Santa Cruz Biotechnology, INC.).
Bioassays
The presence of b-lactams was analysed by a bioassay using
agar plates on which M. luteus cells were plated. Samples were
loaded in wells in the plates and growth was monitored upon
overnight incubation at 30uC. To detect the formation of b-
lactams in vitro, crude extracts were prepared in buffer A
containing 100 mM Tris-HCl pH 8.0, 20% glycerol, 2 mM
DTT, 25 mM KCl and 1 mM PMSF. Small molecules were
removed from P. chrysogenum crude extracts by gel filtration using a
PD-10 column. Extracts were incubated at 25uC in buffer A
supplemented with 5 mM AAA, 1 mM L-cysteine, 5 mM L-
valine, 5 mM ATP, 20 mM MgCl2, 0.43 mM FeSO4. 7H2O and
14.1 mM L-ascorbic acid. After 60 min of incubation, the reaction
was terminated by addition of 5 mM of EDTA pH 8.0. The
presence of b-lactams was monitored using the bioassay as detailed
above. As a control, samples were incubated with b-lactamase
(50,000 IU per reaction) prior to termination of the reaction.
Detection of Metabolites
10 ml of chemostat broth was sampled directly into a filtration
beaker containing 50 ml of a 240uC 60% v/v aqueous methanol
quenching solution. The quenched cells were filtered over a glass
fiber filter (type A/E, Pall Corporation, East Hills, NY, USA,
47 mm diameter, 1 mm pore size) and was washed with 2650 ml
of the quenching solution to completely remove extracellular
metabolites. For accurate quantification purposes by IDMS [29]
100 mlo f
13C internal standard solution was added to the cells.
This
13C internal standard solution contained all relevant
metabolites as U-
13C-labeled isotopes. Immediately after the cells
were submerged in a tube containing 30 ml of a 73uC 75% v/v
aqueous ethanol solution. The tube was vigorously mixed and
transferred to a water bath at 95uC for 5 min for extraction of
metabolites and inactivation of enzymes. The extract was
concentrated under vacuum and analysed via ion-pair reversed-
phase liquid chromatography-isotope dilution tandem mass
spectrometry (IP-LC-ESI-ID-MS/MS) as described previously
[30]. The same analysis method was used to determine
extracellular metabolite concentrations in quenched and filtered
chemostat broth, which was obtained as described previously [31].
The concentration of intracellular metabolites were calculated,
assuming a cellular liquid content of 2.38 ml per g dry weight [32].
Mass Spectrometry Analysis of b-Lactams
For liquid chromatographical analysis, samples were separated
on a C18 capillary column (Waters sunfire C18, 2.16150 mm,
1.8 mm particle size LC column, Waters Chromatography B.V
The Netherlands) coupled to an Accela pump (Thermo Electron
Corporation). The injection volume was 25 ml, the flow rate
200 ml/min and the elution temperature 30uC. Gradients were
prepared using solution A (20 mM ammonium formate in milli Q
water) and solution B (a 1:1 mixture of 20 mM ammonium
formate in milli Q water and acetonitrile). A gradient of 5–50%
solution B was ran during 12 min, followed by a gradient of 50–
65% solution B during 3 min, a washing step with a gradient of
65–5% solution B during 3 min followed by regeneration of the
column with 5% solution B. As controls, standard IPN
(synthesized by Syncom B.V., the Netherlands) and PenG (Sigma
Aldrich) solutions were analysed to determine their respective
retention times. Following LC separation, the eluates were directly
analysed by mass determination using an LTQ orbitrap (Thermo
Electron Corporation). MS data acquisition was performed in
positive ion mode. For structure determination MS/MS was
performed using LTQ XL (Thermo Electron Corporation) with
an m/z range of 200–1000.
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